NYSE · MDT

Medtronic PLC

$84.22 +$1.01 (+1.21%) 1D After hours
Session Pulse Overnight session 1 mentions on Fri · 1 bullish / 0 bearish tags No new SEC filings since Mon close its sector ranked 5/11 this week Full pulse →
Charting by TradingView

Key Metrics

$106.51B
Market cap
22.19×
P/E · TTM
$36.36B
Revenue · TTM
$4.80B
Net income
EPS · TTM $3.61
Dividend yield 3.4%
Free cash flow $5.43B
Beta · 1Y 0.23
EBITDA · TTM $9.09B
Gross margin —

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jun 2
    From its Feb 3 high, the share price fell 29%.

    Peak close $103.18 on Feb 3; trough close $73.75 on Jun 2. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -29%

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$106.51B
Enterprise value$125.25B
Shares outstanding1.3B
52-wk range$73.31 – $106.33
Avg volume · 20D6.4M
Net cash −$18.74B
Book value / share$37.18
IndustryElectromedical & Electrotherapeutic Apparatus
ExchangeNYSE
About Medtronic PLC
IPO dateJun 1, 1972
Employees95000

One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases.

Wolf Grade COMING SOON

—

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E22.19
P/S2.93
P/FCF19.63
EV/EBITDA13.77
EV/Sales3.44
Graham №$54.95

Profitability

Gross —
Operating 16.9%
Net 13.2%
FCF 14.9%
ROE / ROIC 9.8% · 7.1%

Financial Health

Current ratio2.13
Quick ratio1.62
Debt / equity0.57
Debt / EBITDA 3.07
Net cash −$18.74B
Working capital$13.13B

Cash Flow · TTM

Operating CF $7.33B
Capex −$1.90B
Free cash flow $5.43B
Buybacks $1.04B
Dividends paid $3.64B
Shareholder yield 4.4%

Piotroski F-Score

6 / 9
Middling fundamentals · 6 of 9 signals passing

Altman Z-Score

2.8
Grey zone (1.81–2.99) · monitor

Graham Number vs Price

$54.95 vs $84.22
Trades 1.5× above classic defensive value — priced for growth
Fundamentals through 2026-01-23 · computed by TickerWolf from SEC filings